✦ LIBER ✦

FDA and surrogate endpoints in Alzheimer's disease

✍ Scribed by Osborne, Randy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate endpoints in Parkinson’s disea

✍ Kevin M. Biglan; Robert G. Holloway 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 415 KB

Surrogate endpoints and emerging surroga

✍ Crystal M Rasnake; Paula R Trumbo; Therese M Heinonen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

The validity of biomarkers as surrogate

✍ C. C. Gispen-De Wied; M. Kritsidima; A. J. A. Elferink 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 107 KB

Analytic methods for factors, dimensions

✍ R. E. Tractenberg 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 89 KB

Announcing AAPS and FDA Agreement to Bui

✍ Peter Inchauteguiz 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 43 KB

Exploring and validating surrogate endpo

✍ Tomasz Burzykowski; Marc Buyse; Greg Yothers; Junichi Sakamoto; Dan Sargent 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 328 KB